Based on the Tumor Immune Estimation Resource (TIMER) database, we identified a positive correlation between IGF2 expression and the infiltration level of CAFs in both BRCA and COAD (Supplemental Figure 2B). The gene discussed is IGF2; the disease is colon adenocarcinoma.